Bifidobacterium lactis UABla-12 and No Change in Adverse Events

• The efficacy and safety of oral microecological agents as add-on therapy for atopic dermatitis: A systematic review and meta-analysis of randomized clinical trials.

  • 2023-12
  • Review · n = 1,230
  • Clinical and translational allergy 13(12)
  • • Peiwen Xue
    • Haiyan Qin
    • Di Qin
    • Huilin Liu
    • Juan Li
    • Rongjiang Jin
    • Xianjun Xiao

  • PubMed: 38146806
  • DOI: 10.1002/clt2.12318

  2 Insights on

  • No Change in Adverse Events

  • High evidence

  adverse events, pruritus scores, quality of life, and frequency of TCS use showed no significant difference in this meta-analysis study (p > 0.05).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No